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Abstract
Purpose of Review Current traditional treatments for ADHD present serious limitations in terms of long-term maintenance of
symptom remission and side effects. Here, we provide an overview of the rationale and scientific evidence of the efficacy of
neurofeedback in regulating the brain functions in ADHD.We also review the institutional and professional regulation of clinical
neurofeedback implementations.
Recent Findings Based on meta-analyses and (large multicenter) randomized controlled trials, three standard
neurofeedback training protocols, namely theta/beta (TBR), sensori-motor rhythm (SMR), and slow cortical potential
(SCP), turn out to be efficacious and specific. However, the practical implementation of neurofeedback as a clinical
treatment is currently not regulated.
Summary We conclude that neurofeedback based on standard protocols in ADHD should be considered as a viable treatment
alternative and suggest that further research is needed to understand how specific neurofeedback protocols work. Eventually, we
emphasize the need for standard neurofeedback training for practitioners and binding standards for use in clinical practice.
Keywords Neurofeedback . ADHD . Current status . Brain computer interface . Clinical practice
Introduction
Similar to many of his 9-year-old school peers, Brian was put
on psychostimulants after complaints of poor concentration
and impulsivity that met ADHD diagnostic criteria. Despite
a remarkable improvement in his academic performance, par-
ent and teachers noticed a reduction in appetite and weight
loss after the onset of the medication. Moreover, when not
under the effects of medication, inattention and impulsivity
rebounded creating innumerous embarrassments to him and
his family. His parents are now considering neurofeedback—a
non-pharmacological and non-invasive intervention that has
shown promising results in managing the ADHD symptoms
in the long run and without side effects [1].
Despite being the most often applied and accepted treatments
for ADHD, recent large-scale studies and meta-analyses have
demonstrated limitations of psychostimulants and behavioral
therapy. Thus, research and the development of non-
pharmacological treatments such as neurofeedback have been
recommended. To date, however, the clinical value of
neurofeedback is still debated, with evaluations ranging from
“efficacious and specific” [2, 3] to “fails to support
neurofeedback as an effective treatment for ADHD”. [4•] In this
contribution, we will introduce neurofeedback and review the
application of neurofeedback to ADHD as well as its past and
current evidence in the treatment of ADHD. We will also at-
tempt to reconcile these seemingly discrepant research findings.
Current Treatment Approaches in ADHD Several guidelines
exist for the diagnosis and treatment of children who have or
are suspected of having ADHD. Among these are international,
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national, and various regional guidelines for general practi-
tioners. Additionally, there are guidelines for youth aid and
youth protective services.
Traditionally, the treatment of ADHD consists of pharma-
cotherapy, often complemented by behavioral therapy based
on parent management training and mediation training for
parents and teachers [5]. Additionally, classroom interven-
tions, academic interventions, and peer-related interventions
are being used as psychosocial therapeutic approaches [6].
Regarding pharmacotherapy, the administration of methyl-
phenidate is often the method of choice (e.g., Ritalin,
Concerta, Equasym, Medikinet); however, D-amphetamine,
as well as non-psychostimulants, such as atomoxetine and
guanfacine, are prescribed too [7]. Over the past years, the
Multimodal Treatment Study of Children with ADHD and
follow-up studies (the so-called MTA studies) have provided
ample research regarding stimulant medication, behavioral
treatments, their combination, and self-chosen community
care. Results demonstrate that both stimulant medication and
a combined treatment had a clear clinical benefit in the short
term, but on the long-term group differences attenuate, as
assessed after 24 months, as well as after 6 and 8 years [8].
These findings, in combination with studies indicating the
potential side effects of pharmacotherapy [9•, 10], partial drug
response [7], and the time and cost intensiveness of combining
treatments due to the involvement of multiple professionals
[6], have resulted in a growing interest into the development
of alternative non-pharmacological treatments in ADHD.
For instance, computerized cognitive–based training ap-
proaches (e.g., working-memory and attention training) aim
to reduce ADHD core symptoms and tackle neuropsycholog-
ical functioning. Research into this topic is still in the early
stages and more controlled studies regarding the effects on
ADHD core symptoms are required [11]. Another alternative
treatment method for ADHDwhich is alreadymore extensive-
ly studied in the past is neurofeedback. In the following par-
agraphs, we will (i) introduce neurofeedback, (ii) present stan-
dard protocols for ADHD, (iii) review the past and current
evidence in the treatment of ADHD, and (iv) depict the current
status of institutional and professional regulation of the clini-
cal implementation of neurofeedback.
Definit ion, History, and Mechanism of Action of
Neurofeedback Despi te the recent popular i ty of
neuromodulation techniques, neurofeedback is for the most
part still an unknown territory. Neurofeedback is based on a
brain-computer interface (BCI) and is implemented by a soft-
ware system and a processing pipeline, altogether consisting
of five elements (Fig. 1) [12•]. Neurofeedback measures the
participant’s own brain activity, which is pre-processed (steps
1 and 2). Pre-selected brain parameters (a specific frequency
band or a brain potential) are calculated online (step 3) and
translated to signals that are fed back to the user in real time
(step 4). Thus, selected features of brain activity are made
perceivable for the participant. Through this feedback, the
participant (step 5) can learn to self-regulate his own brain
activity to directly alter the underlying neural mechanism of
cognition and behavior.
It has been proposed that neurofeedback is based on prin-
ciples of operant conditioning and procedural skills learn-
ing. Due to these learning mechanisms, neuroplasticity is
expected to take place during neurofeedback training either
via Hebbian plasticity or anti-Hebbian/homeostatic plastic-
ity. Such intrinsic regulatory mechanisms are believed to
prevent extreme states of brain activity, such as pathologi-
cally high or low synaptic strengths or oscillatory states; for
further reading, see [13•].
Nowadays, neurofeedback is used in three ways: (i) as a
therapeutic tool to normalize deviating brain activity and treat
neurocognitive disorders, (ii) as a so-called peak performance
training to enhance cognitive performance in healthy partici-
pants, and (iii) as an experimental method to investigate the
causal role of neural oscillations in cognition and behavior.
More precisely, the neurofeedback research is dominated by
two streams: clinical research and neuroscientific inspired re-
search, which is mainly based on recent methodological and
technical innovations, as well as on an increasing knowledge
about the neural correlates of behavior and cognition. Some
examples of recently developed EEG neurofeedback proto-
cols are the upregulation or downregulation of high alpha
[14, 15], the upregulation of frontal beta [16], and frontal
midline theta [17], but also neurofeedback protocols using
fMRI neurofeedback [18•].
Historically, neurofeedback dates back to the initial discov-
ery of the human electroencephalogram (EEG) by Hans
Berger. Only 6 years after this breakthrough, two French
researchers—Gustave Durup and Alfred Fessard—first re-
ported that the EEG alpha rhythm could be subject to classical
conditioning [19], which is thought to be one of the basic
premises of neurofeedback. This initial observation was
followed up bymore systematic studies in the early 1940s that
further demonstrated all of the Pavlovian types of conditioned
responses could be demonstrated on the “EEG alpha blocking
response”. [20] In a follow-up study, Jasper and Shagass [21]
investigated further whether participants could also exert vol-
untary control over this alpha blocking response. In this study,
they had participants press a button, which would switch the
lights on and off, and use subvocal verbal commands when
pressing the button, (e.g., “Block” when pressing the button
and “Stop”when releasing the button). After five sessions, the
subject was able to voluntarily suppress alpha activity, while
the lights were off (a condition where normally synchronous
alpha would be present). Despite these early developments, it
was only in the 1970s that these same principles were applied
more systematically, and the first clinical implications were
described in the literature. These developments were
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motivated by the discovery of the anticonvulsant effects of
sensori-motor rhythm (SMR) neurofeedback in cats [22]
and subsequently humans [23]. The presumed role of
SMR modulation on motor behavior was followed by the
first demonstrations of the positive effects of SMR
neurofeedback in hyperkinetic disorder [24]. Around the
same 1960–1970 period, the first report of voluntary control
over a slow brain potential called the contingent negative
variation (CNV) or “bereitschaftspotential” (readiness po-
tential, due to the property of this potential to emerge when
preparing for action, e.g., when waiting in front of a traffic
light) was reported [25], which laid the foundation of anoth-
er well-known neurofeedback approach, namely of slow
cortical potential (SCP) neurofeedback. The first applica-
tion of SCP neurofeedback in ADHD was reported in
2004 [26]. The initial findings described above as SMR
and TBR neurofeedback resulted into what we currently
known as “frequency band neurofeedback.”
Standard Protocols with ADHD
Theta/beta (4–7 Hz/12–21 Hz) ratio (TBR) neurofeedback
strives to decrease theta and/or increase beta power in central
and frontal locations. This protocol directly targets important
electrophysiological characteristics such as high theta/beta ra-
tios, high theta power, and/or low beta power commonly
observed in children (for a review, see [27]) and adults with
ADHD [28–30]. Recent randomized controlled trials suggest
that 30 to 40 sessions of TBR neurofeedback were as effective
as methylphenidate in reducing inattentive and hyperactivity
symptoms and were even associated with superior post-
treatment academic performance [31, 32]. It has been pro-
posed that the effects of TBR neurofeedback on ADHDmight
be explained by the learned self-regulation of attention [33] as
evidenced by enhanced amplitude of endogenous evoked-
related potentials such as the P300 [34]. However, more neu-
roscientific evidence is needed to determine the specificmech-
anisms by which TBR neurofeedback might impact cognitive
functioning in ADHD.
SMR neurofeedback training over the sensori-motor
strip (predominantly in the central right hemispheric re-
gion) was first applied to ADHD children by Lubar and
colleagues [24, 35], based on the functional association
of the sensori-motor rhythm with behavioral inhibition
and the promising results in reducing cortical excitability
in epileptics obtained by Sterman, MacDonald, and
Stone [36]. Lubar’s seminal studies revealed that the
beneficial hyperactivity-reducing effects of a combined
SMR/theta neurofeedback training were maintained after
psychostimulants was withdrawn in hyperactive children.
Studies suggest that SMR neurofeedback training reduces
inattentive and hyperactive/impulsive symptoms in ADHD
children to the same extent as TBR training and comparable
Fig. 1 Overview neurofeedback: neurofeedback pipeline and three areas of neurofeedback application. The pipeline includes the five most important
processing steps and parts of a neurofeedback system
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number of treatment sessions. However, the two protocols
might achieve the same results through distinct mechanisms.
Arns, Feddema, and Kenemans [37] provided evidence that
ADHD patients trained with the SMR protocol showed de-
creased sleep onset latency (SOL) and improved sleep quality
in comparison to those administered with TBR, midway treat-
ment. Amediation analysis revealed that this normalized sleep
mid-treatment was responsible for the improved inattention
post-treatment. The improvements in ADHD symptoms fol-
lowing SMR training might hence be the result of the vigi-
lance stabilization mediated by the regulation of the locus
coeruleus noradrenergic system of which activation has been
shown to impact the sleep spindle circuitry [38]. This expla-
nation seems to be in line with previous indications that pa-
tients with ADHD present delays in SOL [39] and that SMR
training increases sleep spindle density and improves sleep
quality in healthy adults [40].
Another standard protocol is the self-regulation of SCP [41,
42••] after around 35 sessions. SCP neurofeedback is based on
the learned self-regulation of cortical activation and inhibition
which are associated with the electrical negativation and
positivation of slow cortical electrical deflections respectively.
These periodical shifts from electrical positivity to negativity
have been described as a phasic tuning mechanism in the
regulation of attention [43] as shown by the enhanced reaction
time, stimulus detection, and short-term memory during the
negative shift phase [44]. Since SCP, of which the CNV is an
example, are closely associated with preparatory motor re-
sponses with a maximal topographic representation in the mo-
tor areas, the vertex is usually the site of choice for training.
Differently from TBR and SMR protocols which are typically
unidirectional (i.e., instructions either require the participant to
increase or decrease the power of the EEG parameter), the
self-regulation of SCP usually involves the training in gener-
ating both cortical activation and inhibition. In the case of
ADHD, the therapeutic focus is on promoting an increase in
the firing probabilities of the underlying cortical areas (i.e.,
negativation). Another difference relative to frequency
neurofeedback is that in SCP neurofeedback the learning trials
are higher in number and considerably shorter in duration.
Interestingly, it has been hypothesized that SCP might also
be associated with improvements in sleep. The generation of
slow oscillations, in particular negative slow direct current,
shifts training during SCP neurofeedback, might exert control
over the sleep spindle circuit and therefore facilitate the tran-
sition from wakefulness to sleep [45].
Current Status of Efficacy of Standard
Protocols for Neurofeedback in ADHD
Aswith any emerging new treatments, knowledge of technical
aspects of the treatment, proper standards, and education are
crucial for appropriately evaluating the merits and pitfalls of
neurofeedback. Unfortunately, the unfounded assumption that
“neurofeedback = neurofeedback” is often made.
Neurofeedback can differentially impact brain functioning de-
pending on the kind protocol and implementation the same
way as different pharmacological treatments do (e.g., antide-
pressants and analgesic drugs). As an illustration,
neurofeedback treatments such as the earlier mentioned
SMR, TBR, and SCP neurofeedback are well-investigated
and effective in the treatment of ADHD while other ap-
proaches such as posterior alpha enhancement have been
found to be not effective (for a review, see [3].
Especially when restricted to standard protocols such as
TBR, SMR, and SCP protocols [3], neurofeedback is a
well-investigated treatment for ADHD. This has become
evident from several meta-analyses [2, 46••, 47], including
a critical meta-analysis from the European ADHD
Guidelines Group (EAGG) that also conducted a sensitiv-
ity analysis focused on so called “blinded” ratings (i.e.,
teacher reports only) [4•]. Blinded ratings have usually
lower effects sizes than ratings by people most-proximal
to the child and therefore least blinded (e.g., parents) and
both rating types are only modestly correlated [48]. One
explanation for this may be that the rating types focus on
different aspects of ADHD symptoms. This is reflected in
studies showing different rating-ADHD aspect associa-
tions, as for instance parent ratings of hyperactive-
impulsive behaviors were found to be correlated with ge-
netics [49], whereas teacher ratings have been shown to be
associated to medication effects [50], most likely due to
the fast onset of action of psychostimulants. To come back
to the latter meta-analysis [4•], the researchers did not find
an effect of neurofeedback in general on teacher-rated
ADHD symptoms, but there was an effect when the anal-
ysis was restricted to the above mentioned “standard pro-
tocols.” Finally, a recent meta-analysis that included 10
RCTs and specifically looked at long-term effects of
neurofeedback, compared to active treatments (including
psychostimulants) and semi-active treatments (e.g., cogni-
tive training), found that after on average 6 months follow-
up, the effects of neurofeedback were superior to semi-
active control groups and no different from active treat-
ments including methylphenidate [46••]. Interestingly, this
meta-analysis confirmed the trend for medication effects to
diminish with time, and the effects of neurofeedback—
without additional sessions being conducted—to increase
with time. These data suggest the promising aspect, name-
ly of long-term efficacy, of neurofeedback. Currently, one
of the largest and most comprehensive double-blind mul-
tisite RCT is carried out: the International Collaborative
ADHD Neurofeedback study (ICAN). This study consists
of a cross-site investigation team with different back-
ground of ADHD treatment approaches assessing 140
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participants in total (see the study design in [51]), and
results are foreseen to be published in 2019.
Current Status of Institutional
and Professional Regulation of Clinical
Neurofeedback Implementations
Although standard protocols turn out to be efficacious and spe-
cific, the practical implementation of neurofeedback as a clin-
ical therapy is currently not regulated. This applies to the edu-
cational standards, medical security, and the usage of standard
protocols indicated for specific disorders such as ADHD. The
lack of regulation and agreed upon standards comes with the
danger of patients being treated with ineffective neurofeedback
protocols applied by unlicensed personal (or even worse by
people without any health-related background). For instance,
although practitioners should stick to standard protocols with
functional specificity of the frequency and topographic loca-
tions, clinical practice often deviates from what is recommend-
ed by research. The lack of regulation and missing standards
have furthermore caused a surge in commercial driven applica-
tions and proclaimed “innovations” of neurofeedback protocols
and implementations. Several studies have now demonstrated
that some of those “innovations” and implementations do not
work. One example of such ineffective technique is the
SmartBrain neurofeedback approach using the “NASA patent-
ed engagement index” with Sony PlayStation feedback [51,
52]. Additionally, there is no evidence in favor of the efficacy
of unconventional neurofeedback protocols used in some
neurofeedback clinics [53] and frequently advertised applica-
tions such as Z score and LORETA neurofeedback [54].
Unfortunately, these proclaimed innovations and commercial-
driven applications only add noise to the ongoing debate of
neurofeedback efficacy and risk “throwing the baby out with
the bathwater.” However, above all this demonstrates the need
for further research into the effectiveness of already available
and newly developed neurofeedback protocols (i.e., the number
of sessions, targeted brain area, selected brain parameter, work-
ing mechanism) in addition to proper “agreed-upon standards”
and training within the field of neurofeedback.
Neurofeedback researchers and practitioners can affili-
ate to scientific and professional organizations at the in-
ternational and national level. On an international level,
there are mainly two societies. The Society of Applied
Neuroscience (SAN) (http://www.applied-neuroscience.
org/) is an EU-based nonprofit membership organization
for the advancement of neuroscientific knowledge and de-
velopment of innovative applications for optimizing brain
functioning (such as neurofeedback with EEG, fMRI,
NIRS). The International Society for Neurofeedback &
Research (ISNR (https://www.isnr.org) is a membership
organization aimed at supporting scientific research in
applied neurosciences, promoting education in the field
of neurofeedback, albeit not always clearly separating
commercial and objective interests. Other neurofeedback
societies or organizations are often connected to certain
neurofeedback equipment manufacturers and have
(seemingly) conflicting interests. Furthermore, the
Biofeedback Certification International Alliance (BCIA)
is a broader international licensure also including biofeed-
back (www.BCIA.org).
Conclusions
Recent years witness a renewed interest in neurofeedback
in response to the lack of long-term effects for both med-
ication and behavioral therapy and the side effects of
medication. Herein, we provide evidence for the efficacy
and specificity of standard neurofeedback protocols,
namely theta/beta, sensori-motor rhythm, and slow corti-
cal potential. In line with the guidelines for rating evi-
dence developed by the APA, “standard” neurofeedback
protocols have been considered to be “Efficacious and
Specific, Level V” in the treatment of ADHD (AAPB
Guidelines: [57]).
However, currently there are no uniform standards re-
garding training courses for neurofeedback that are ac-
cepted by expert associations, neither national-wide, nor
in the EU or USA. While performing neurofeedback in a
therapeutic context, a thorough basic training, a distinct
technical understanding of the medical devices, the soft-
ware, and the EEG caps, as well as continuing education,
are imperative. Regarding the medical security performing
neurofeedback in a clinical context, neurofeedback de-
vices (hardware: amplifier and EEG caps, neurofeedback
software) are neither regulated in a strict way. However, it
is essential that besides the absolute minimum technical
requirements after the Medical Device Regulation (MDR)
EU 2017/745), neurofeedback devices should be regulated
by both the CE (that confirms a medical device meets the
essential MDR requirements) and a European equivalent
of the Food and Drug Administration (FDA). The FDA
enforces laws to protect the consumer’s health, safety, and
pocketbook. Such potential regulating mechanisms could
be implemented by the European medicine regulatory net-
work. In short , tasks ahead concern regulat ing
neurofeedback as therapy, developing internationally ac-
cepted binding standards for education and NF implemen-
tation and the qualification of neurofeedback trainers.
Last but not least, Brian—now 4 years later—discontinued
his medication successfully under medical supervision. Due to
neurofeedback, his impulsivity symptoms strongly reduced
and he gained control over his concentration, doing well in
high school performance.
Curr Psychiatry Rep (2019) 21: 46 Page 5 of 7 46
Compliance with Ethical Standards
Conflict of Interest Stefanie Enriquez-Geppert and Diede Smit each
declare that they have no conflict of interest. Miguel G Pimenta declares
that he is a lecturer in neurofeedback for the neuroCare Group (Munich,
Germany). Martijn Arns (MAr) reports research grants and options from
Brain Resource (Sydney, Australia); owns stock in and serves as Chief
Scientific Adviser of the neuroCare Group (Munich, Germany) and
Director and Researcher of Research Institute Brainclinics (Nijmegen,
Netherlands); is a consultant on a National Institute of Mental Health,
US-funded iCAN study (CNG 2013); and is a co-inventor on four patent
applications (A61B5/0402; US2007/0299323, A1;WO2010/139361 A1;
one pending) related to EEG, neuromodulation, and psychophysiology
(not related to neurofeedback). MAr declares no ownership or financial
gains for these patents - just authorship.
Human and Animal Rights and Informed Consent This article does not
contain any studies with human or animal subjects performed by any of
the authors.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
Papers of particular interest, published recently, have been
highlighted as:
• Of importance
•• Of major importance
1. Hammond DC, Kirk L. Negative effects and the need for standards
of practice in neurofeedback. Biofeedback. 1982;35(4):139–45.
2. Arns M, de Ridder S, Strehl U, Breteler M, Coenen A. Efficacy of
neurofeedback treatment in ADHD: the effects on inattention, im-
pulsivity and hyperactivity: a meta-analysis. Clin EEG Neurosci.
2009;40(3):180–9.
3. Arns M, Heinrich H, Strehl U. Evaluation of neurofeedback in
ADHD: the long and winding road. Biol Psychol. 2014;95:108–15.
4.• Cortese S, Ferrin M, Brandeis D, Holtmann M, Aggensteiner P,
Daley D, et al. Neurofeedback for attention-deficit/hyperactivity
disorder: meta-Analysis of clinical and neuropsychological out-
comes from randomized controlled trials. J Am Acad Child
Adolesc Psychiatry. 2016;55(6):444–55. This meta-analysis
shows that there is only an effect on blinded teacher ratings
for ADHD symptoms for standard protocols, but not when
assessing all available neurofeedback protocols.
5. Taylor E, Dopfner M, Sergeant J. European clinical guidelines for
hyperkinetic disorder – first upgrade. Eur Child Adolesc Psychiatry.
2004;13(Suppl 1):i7–i30.
6. Daly BP, Creed T, XanthopoulosM, Brown RT. Psychosocial treat-
ments for children with attention deficit/hyperactivity disorder.
Neuropsychol Rev. 2007;17(1):73–89.
7. Faraone SV, Buitelaar J. Comparing the efficacy of stimulants for
ADHD in children and adolescents using meta-analysis. Eur Child
Adolesc Psychiatry. 2010;19(4):353–64.
8. Molina BSG, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B,
Jensen PS, et al. The MTA at 8 years: prospective follow-up of
children treated for combined-type ADHD in a multisite study. J
Am Acad Child Adolesc Psychiatry. 2009;48(5):484–500.
9.• Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M,
Holmskov M, et al. Methylphenidate for children and adolescents
with attention deficit hyperactivity disorder (ADHD). Cochrane
Database Syst Rev. 2015;11:CD009885. In this article, the side
effects of methylphenidate are systematically presented.
10. Charach A, Figueroa M, Chen S, Ickowicz A, Schachar R.
Stimulant treatment over 5 years: effects on growth. J Am Acad
Child Adolesc Psychiatry. 2006;45(4):415–21.
11. Sonuga-Barke EJ, Brandeis D, Holtmann M, Cortese S. Computer-
based cognitive training for attention-deficit/hyperactivity disorder:
a review of current evidence. Child Adolesc Psychiatr Clin N Am.
2014;23(4):807–24.
12.• Enriquez-Geppert S, Huster RJ, Herrmann CS. EEG-
neurofeedback as a tool to modulate cognition and behavior: a
review tutorial. Front Hum Neurosci. 2017;11:51. This review
gives an overview of the key aspects relevant to the develop-
ment of neurofeedback protocols and discusses the relevant
aspects for the practical application of neurofeedback.
13.• Ros T, Baars BJ, Lanius RA, Vuilleumier P. Tuning pathological
brain oscillations with neurofeedback: a systems neuroscience
framework. Front Hum Neurosci. 2014;8:1008. This article in-
cludes a section about the currently known mechanisms of ac-
tions of neurofeedback.
14. Escolano C, Aquilar M, Minguey J. EEG-based upper alpha
neurofeedback training improves working memory performance.
Conf Proc IEEE Eng Med Biol Soc. 2011:2327–30.
15. Ros T, Munneke M, Ruge D, Gruzelier J, Rothwell J. Endogenous
control of waking brain rhythms induces neuroplasticity in humans.
Eur J Neurosci. 2010;31(4):770–8.
16. Engelbregt HJ, Keeser D, Van Eijk L, Suiker EM, Eichhorn D,
Karch S, et al. Short and long-term effects of sham-controlled pre-
frontal EEG-neurofeedback training in healthy subjects. Clin
Neurophysiol. 2016;127(4):1931–7.
17. Enriquez-Geppert S, Huster RJ, Figge C, Herrmann CS. Self-
regulation of frontal-midline theta facilitates memory updating
and mental set shifting. Front Behav Neurosci. 2014;8:420.
18.• Alegria AA,Wulff M, Brinson H, Barker GJ, Norman LJ, Brandeis
D, et al. Real-time fMRI neurofeedback in adolescents with atten-
tion deficit hyperactivity disorder. Hum Brain Mapp. 2017;38(6):
3190–209. This article presents the effects of fMRI
neurofeedback on dysregulated brain regions in ADHD.
19. Durup G, Fessard A. I. L’électrencéphalogramme de l’homme.
Observations psycho-physiologiques relatives à l’action des stimuli
visuels et auditifs. Ann Psychol. 1935;36(1):1–32.
20. Jasper H, Shagass C. Conditioning the occipital alpha rhythm in
man. J Exp Psychol. 1941;28(5):373–88.
21. Jasper H, Shagass C. Conscious time judgments related to condi-
tioned time intervals and voluntary control of the alpha rhythm. J
Exp Psychol. 1941;28(6):503–8.
22. Sterman B, LoPresti RW, Fairchild MD. Electroencephalographic
and behavioral studies of monomethylhydrazine toxicity in the cat.
J Neurother. 2010;14(4):293–300.
23. Sterman MB, Friar L. Suppression of seizures in an epileptic fol-
lowing sensorimotor EEG feedback training. Electroencephalogr
Clin Neurophysiol. 1972;33(1):89–95.
24. Lubar JF, Shouse MN. EEG and behavioral changes in a hyperki-
netic child concurrent with training of the sensorimotor rhythm
(SMR). Biofeedback Self Regul. 1976;1(3):293–306.
25. McAdam DW, Irwin DA, Rebert CS, Knott JR. Conative control of
the contingent negative variation. Electroencephalogr Clin
Neurophysiol. 1966;21(2):194–5.
26. Heinrich H, Gevensleben H, Freisleder FJ, Moll GH, Rothenberger
A. Training of slow cortical potentials in attention-deficit/
46 Page 6 of 7 Curr Psychiatry Rep (2019) 21: 46
hyperactivity disorder: evidence for positive behavioral and neuro-
physiological effects. Biol Psychiatry. 2004;55(7):772–5.
27. Barry RJ, Clarke AR, Johnstone SJ. A review of electrophysiology in
attention-deficit/hyperactivity disorder: I. Qualitative and quantitative
electroencephalography. Clin Neurophysiol. 2003;114(2):171–83.
28. Bresnahan SM, Barry RJ. Specificity of quantitative EEG analysis
in adults with attention deficit hyperactivity disorder. Psychiatry
Res. 2002;112(2):133–44.
29. Bresnahan SM, Anderson JW, Barry RJ. Age-related changes in
quantitative EEG in attention-deficit/hyperactivity disorder. Biol
Psychiatry. 1999;46(12):1690–7.
30. Clarke AR, Barry RJ, Heaven PCL, McCarthy R, Selikowitz M,
Byrne MK. EEG in adults with attention-deficit/hyperactivity dis-
order. Int J Psychophysiol. 2008;70(3):176–83.
31. Duric NS, Assmus J, Gundersen D, Elgen IB. Neurofeedback for
the treatment of children and adolescents with ADHD: a random-
ized and controlled clinical trial using parental reports. BMC
Psychiatry. 2012;12:107.
32. Meisel V, Servera M, Garcia-Banda G, Cardo E, Moreno I.
Neurofeedback and standard pharmacological intervention in
ADHD: a randomized controlled trial with six-month follow-up.
Biol Psychol. 2013;94(1):12–21.
33. Gevensleben H, Rothenberger A, Moll GH, Heinrich H.
Neurofeedback in children with ADHD: validation and challenges.
Expert Rev Neurother. 2012;12(4):447–60.
34. Egner T, Gruzelier JH. EEG biofeedback of low beta band compo-
nents: frequency-specific effects on variables of attention and event-
related brain potentials. Clin Neurophysiol. 2004;115(1):131–9.
35. Shouse MN, Lubar JF. Operant conditioning of EEG rhythms and
Ritalin in the treatment of hyperkinesis. Biofeedback Self Regul.
1979;4(4):299–312.
36. Sterman MB, Macdonald LR, Stone RK. Biofeedback training of
the sensorimotor electroencephalogram rhythm in man: effects on
epilepsy. Epilepsia. 1974;15(3):395–416.
37. Arns M, Feddema I, Kenemans JL. Differential effects of theta/beta
and SMR neurofeedback in ADHD on sleep onset latency. Front
Hum Neurosci. 2014a;8:1019.
38. Sinha SR. Basic mechanisms of sleep and epilepsy. J Clin
Neurophysiol. 2011;28(2):103–10.
39. Van Veen MM, Kooij JJS, Boonstra AM, Gordijn MCM, Van
Someren EJW. Delayed circadian rhythm in adults with attention-
deficit/hyperactivity disorder and chronic sleep-onset insomnia.
Biol Psychiatry. 2010;67(11):1091–6.
40. SchabusM,HeibDPJ, Lechinger J, Griessenberger H, KlimeschW,
Pawlizki A, et al. Enhancing sleep quality and memory in insomnia
using instrumental sensorimotor rhythm conditioning. Biol
Psychol. 2014;95:126–34.
41. Gevensleben H, Holl B, Albrecht B, Schlamp D, Kratz O, Studer P,
et al. Distinct EEG effects related to neurofeedback training in chil-
dren with ADHD: a randomized controlled trial. Int J
Psychophysiol. 2009;74(2):149–57.
42.•• Strehl U, Aggensteiner P, Wachtlin D, Brandeis D, Albrecht B,
Arana M, et al. Neurofeedback of slow cortical potentials in chil-
dren with attention-deficit/hyperactivity disorder: a multicenter ran-
domized trial controlling for unspecific effects. Front Hum
Neurosci. 2017;11:135. This multi-center RCT shows clinical
efficacy of standard neurofeedback protocols for ADHD.
43. Rockstroh B, Elbert T, Birbaumer N, Lutzenberger W. Biofeedback-
produced hemispheric asymmetry of slow cortical potentials and its
behavioural effects. Int J Psychophysiol. 1990;9(2):151–65.
44. Birbaumer N, Elbert T, Canavan AG, Rockstroh B. Slow potentials
of the cerebral cortex and behavior. Physiol Rev. 1990;70(1):1–41.
45. Marshall L, Mölle M, Born J. Spindle and slow wave rhythms at
slow wave sleep transitions are linked to strong shifts in the cortical
direct current potential. Neuroscience. 2003;121(4):1047–53.
46.•• Van Doren J, Arns M, Heinrich H, Vollebregt MA, Strehl U, Loo
SK. Sustained effects of neurofeedback in ADHD: A systematic
review and meta-analysis. Eur Child Adolesc Psychiatry. 2018:1–
13. This recent meta-analysis with 10 RCTs shows that the ef-
fects of neurofeedback increase in time, other than medication
effects that diminish with time, and suggest of long-term effica-
cy of neurofeedback.
47. Micoulaud-Franchi JA, Geoffroy PA, Fond G, Lopez R, Bioulac S,
Philip P. EEG neurofeedback treatments in children with ADHD: an
updated meta-analysis of randomized controlled trials. Front Hum
Neurosci. 2014;8:906.
48. Sollie H, Larsson B, MorchWT. Comparison of mother, father, and
teacher reports of ADHD core symptoms in a sample of child psy-
chiatric outpatients. J Atten Disord. 2013;17(8):699–710.
49. Bralten J, Franke B, Waldman I, Rommelse N, Hartman C,
Asherson P, et al. Candidate genetic pathways for attention
deficit/hyperactivity disorder (ADHD) show association to
hyperactive/impulsive symptoms in children with ADHD. J Am
Acad Child Adolesc Psychiatry. 2013;52(11):1204–12.
50. Wang LJ, Chen C-K, Huang YS. Changes in behaviour symptoms
of patients with attention deficit/hyperactivity disorder during treat-
ment: observation from different informants. Psychiatry Investig.
2013;10(1):1–7.
51. Arnold LE, Lofthouse N, Hersch S, Pan X, Hurt E, Bates B,
et al. EEG neurofeedback for ADHD: double-blind sham-con-
trolled randomized pilot feasibility trial. J Atten Disord.
2013;17(5):410–9.
52. DeBeus R, Kaiser D. Neurofeedback with children with attention
deficit hyperactivity disorder: a randomized double-blind placebo-
controlled study. In: Coben R, Evans J, editors. Neurofeedback and
neuromodulation: techniques and applications, vol. 2011. San
Diego: Elsevier; 2011. p. 127–52.
53. Van Dongen-Boomsma M, Vollebregt MA, Slaats-Willemse D,
Buitelaar J. A randomized placebo-controlled trial of electroen-
cephalographic (EEG) neurofeedback in children with attention-
deficit/hyperactivity disorder. J Clin Psychiatry. 2013;74(8):821–7.
54. Coben R, Hammond DC, Arns M. 19 channel z-score and_
LORETA neurofeedback: does the evidence support the hype?
Appl Psychophysiol Biofeedback. 2018:1–8.
Publisher’s Note Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
Curr Psychiatry Rep (2019) 21: 46 Page 7 of 7 46
